Eugene Schneider
EVP, Chf Clinical Develop Ofcr · 4 filings · Latest: Jun 26, 2026
IONIS PHARMACEUTICALS INC
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
IONS | Eugene Schneider | EVP, Chf Clinical Develop Ofcr | Jun 26, 2026 | Sale | $81.05 | 26,000 | $2.1M | 77,114 | |
IONS | Eugene Schneider | EVP, Chf Clinical Develop Ofcr | Jun 26, 2026 | Option Exercise | $60.89 | 26,000 | $1.6M | 103,114 | |
IONS | Schneider Eugene | — | Jun 26, 2026 | Proposed Sale | $81.05 | 47,884 | $3.9M | — | |
IONS | Schneider Eugene | — | Mar 19, 2026 | Proposed Sale | $70.97 | 5,812 | $412.5K | — | Mar 24 8:43 PM 144/A |
IONS | Eugene Schneider | EVP, Chf Clinical Develop Ofcr | Mar 19, 2026 | Sale | $70.97 | 5,812 | $412.5K | 63,890 | |
IONS | Schneider Eugene | — | Mar 19, 2026 | Proposed Sale | $70.97 | 5,812 | $412.5K | — | |
IONS | Eugene Schneider | EVP, Chf Clinical Develop Ofcr | Jan 30, 2026 | Sale | $83.45 | 6,179 | $515.6K | 69,702 | |
IONS | Schneider Eugene | — | Jan 30, 2026 | Proposed Sale | $83.01 | 6,179 | $512.9K | — | |
IONS | Eugene Schneider | EVP, Chf Clinical Develop Ofcr | Jan 16, 2026 | Sale | $75.59 | 9,302 | $703.1K | 63,890 | |
IONS | Eugene Schneider | EVP, Chf Clinical Develop Ofcr | Jan 15, 2026 | Option Exercise | $0.00 | 21,685 | — | 73,192 | |
IONS | Schneider Eugene | — | Jan 16, 2026 | Proposed Sale | $76.23 | 9,302 | $709.1K | — | |
IONS | Schneider Eugene | — | Sep 3, 2025 | Proposed Sale | $60.81 | 19,658 | $1.2M | — | |
IONS | Schneider Eugene | — | Aug 4, 2025 | Proposed Sale | $42.88 | 9,549 | $409.5K | — | |
IONS | Schneider Eugene | — | Jan 31, 2025 | Proposed Sale | $33.00 | 1,700 | $56.1K | — | |
IONS | Schneider Eugene | — | Jan 16, 2025 | Proposed Sale | $32.70 | 6,523 | $213.3K | — | |
IONS | Schneider Eugene | — | Feb 2, 2024 | Proposed Sale | $49.59 | 2,106 | $104.4K | — | Sep 5 1:20 AM 144/A |